• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接种 SARS-CoV-2 疫苗后唾液 IgA 迅速增加和广泛识别刺突蛋白。

Rapid increase in salivary IgA and broad recognition of spike protein following SARS-CoV-2 vaccination.

机构信息

Department of Laboratory Medicine, Nagasaki University Hospital, 1-7-1, Sakamoto, Nagasaki 852-8501, Japan.

CellSpect Co. Ltd., 2-4, Kita Iioka, Morioka, Iwate 020-0857, Japan.

出版信息

Virus Res. 2024 Jan 2;339:199294. doi: 10.1016/j.virusres.2023.199294. Epub 2023 Dec 6.

DOI:10.1016/j.virusres.2023.199294
PMID:38056502
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10749273/
Abstract

Saliva is a key component of mucosal immunity, which protects the oral cavity from viral infections. However, salivary immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in terms of immunoglobulin dynamics and recognition, have not been investigated sufficiently. In this study, saliva samples were collected from individuals that received SARS-CoV-2 vaccine, and immunoglobulin G (IgG), IgM, and IgA against whole spike protein and S1 protein were measured. IgA against whole spike protein increased significantly following vaccination, while IgA against S1 protein did not. Of note, the IgA response was evident two weeks after the first vaccine dose and continued to rise thereafter. On the contrary, IgG antibodies against S1 increased significantly at four weeks after vaccination. These results reveal the dynamics and recognition antigens of immunoglobulins in saliva, indicating the function of IgA in the mucosal immune system. These findings may pave the way for further studies on mucosal immune response induced by vaccination.

摘要

唾液是黏膜免疫的关键组成部分,可保护口腔免受病毒感染。然而,针对严重急性呼吸综合征冠状病毒 2(SARS-CoV-2),唾液免疫反应的免疫球蛋白动力学和识别尚未得到充分研究。在这项研究中,从接种 SARS-CoV-2 疫苗的个体中采集了唾液样本,并测量了针对全刺突蛋白和 S1 蛋白的 IgG、IgM 和 IgA。接种疫苗后,针对全刺突蛋白的 IgA 显著增加,而针对 S1 蛋白的 IgA 没有增加。值得注意的是,IgA 反应在第一剂疫苗接种后两周出现,并在此后继续上升。相反,接种后四周 S1 抗体 IgG 显著增加。这些结果揭示了唾液中免疫球蛋白的动力学和识别抗原,表明 IgA 在黏膜免疫系统中的功能。这些发现可能为进一步研究疫苗诱导的黏膜免疫反应铺平道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5272/10749273/be49dfcf6c7f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5272/10749273/80fcf3d1ccc1/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5272/10749273/be49dfcf6c7f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5272/10749273/80fcf3d1ccc1/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5272/10749273/be49dfcf6c7f/gr1.jpg

相似文献

1
Rapid increase in salivary IgA and broad recognition of spike protein following SARS-CoV-2 vaccination.接种 SARS-CoV-2 疫苗后唾液 IgA 迅速增加和广泛识别刺突蛋白。
Virus Res. 2024 Jan 2;339:199294. doi: 10.1016/j.virusres.2023.199294. Epub 2023 Dec 6.
2
Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines.感染 SARS-CoV-2 后和接种 COVID-19 疫苗后针对 SARS-CoV-2 刺突蛋白的唾液和血清 IgA 和 IgG 反应。
Allergy Asthma Proc. 2022 Sep 1;43(5):419-430. doi: 10.2500/aap.2022.43.220045.
3
Salivary immune responses after COVID-19 vaccination.接种 COVID-19 疫苗后的唾液免疫反应。
PLoS One. 2024 Sep 3;19(9):e0307936. doi: 10.1371/journal.pone.0307936. eCollection 2024.
4
Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination.新型冠状病毒肺炎信使核糖核酸疫苗接种后的血清及唾液免疫球蛋白G和免疫球蛋白A反应
JAMA Netw Open. 2024 Apr 1;7(4):e248051. doi: 10.1001/jamanetworkopen.2024.8051.
5
The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines.新型冠状病毒(SARS-CoV-2)疫苗的黏膜和血清免疫应答。
Front Immunol. 2021 Oct 12;12:744887. doi: 10.3389/fimmu.2021.744887. eCollection 2021.
6
Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection.接种 SARS-CoV-2 mRNA 疫苗后,机体可产生不同程度的系统性和黏膜性 IgA 应答,且与预防后续感染相关。
Mucosal Immunol. 2022 May;15(5):799-808. doi: 10.1038/s41385-022-00511-0. Epub 2022 Apr 25.
7
A Single Dose of BNT162b2 Messenger RNA Vaccine Induces Airway Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Naive and Recovered Coronavirus Disease 2019 Subjects.一剂 BNT162b2 信使 RNA 疫苗可诱导 SARS-CoV-2 初治和恢复期 COVID-19 受试者的气道免疫。
Clin Infect Dis. 2022 Dec 19;75(12):2053-2059. doi: 10.1093/cid/ciac378.
8
Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?接种 COVID-19 疫苗后,人乳中能否检测到 SARS-CoV-2 抗体?
J Pediatric Infect Dis Soc. 2022 Apr 30;11(4):126. doi: 10.1093/jpids/piac024.
9
Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine.接种 BNT162b2 新冠疫苗加强针后的黏膜免疫应答。
EBioMedicine. 2023 Feb;88:104435. doi: 10.1016/j.ebiom.2022.104435. Epub 2023 Jan 9.
10
Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days.接种灭活疫苗后 160 天内血清抗 SARS-CoV-2 抗体的反应和持续时间。
Front Immunol. 2021 Dec 23;12:786554. doi: 10.3389/fimmu.2021.786554. eCollection 2021.

本文引用的文献

1
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection.抗刺突黏膜IgA对SARS-CoV-2奥密克戎感染的保护作用。
N Engl J Med. 2022 Oct 6;387(14):1333-1336. doi: 10.1056/NEJMc2209651. Epub 2022 Sep 14.
2
Mucosal immune response in BNT162b2 COVID-19 vaccine recipients.BNT162b2 新冠疫苗接种者的黏膜免疫应答。
EBioMedicine. 2022 Jan;75:103788. doi: 10.1016/j.ebiom.2021.103788. Epub 2021 Dec 23.
3
The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines.新型冠状病毒(SARS-CoV-2)疫苗的黏膜和血清免疫应答。
Front Immunol. 2021 Oct 12;12:744887. doi: 10.3389/fimmu.2021.744887. eCollection 2021.
4
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel.BNT162b2 疫苗突破性感染:以色列 152 名完全接种疫苗的住院 COVID-19 患者的临床特征。
Clin Microbiol Infect. 2021 Nov;27(11):1652-1657. doi: 10.1016/j.cmi.2021.06.036. Epub 2021 Jul 7.
5
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.BNT162b2 新冠病毒疫苗与体液免疫应答及动力学的相关性:医护人员前瞻性、单中心、纵向队列研究。
Lancet Respir Med. 2021 Sep;9(9):999-1009. doi: 10.1016/S2213-2600(21)00220-4. Epub 2021 Jul 2.
6
Detection of SARS-CoV-2 using qRT-PCR in saliva obtained from asymptomatic or mild COVID-19 patients, comparative analysis with matched nasopharyngeal samples.使用 qRT-PCR 检测无症状或轻症 COVID-19 患者唾液中的 SARS-CoV-2,与配对的鼻咽样本进行比较分析。
PLoS One. 2021 Jun 10;16(6):e0252964. doi: 10.1371/journal.pone.0252964. eCollection 2021.
7
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.中和抗体水平高度预测对有症状的 SARS-CoV-2 感染的免疫保护作用。
Nat Med. 2021 Jul;27(7):1205-1211. doi: 10.1038/s41591-021-01377-8. Epub 2021 May 17.
8
Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection.COVID-19 中的黏膜免疫:被忽视但至关重要的 SARS-CoV-2 感染方面。
Front Immunol. 2020 Nov 30;11:611337. doi: 10.3389/fimmu.2020.611337. eCollection 2020.
9
Saliva is a non-negligible factor in the spread of COVID-19.唾液是 COVID-19 传播中不可忽视的因素。
Mol Oral Microbiol. 2020 Aug;35(4):141-145. doi: 10.1111/omi.12289. Epub 2020 May 31.